NCT05867251 2025-11-19Study of AVZO-021 in Patients With Advanced Solid TumorsAvenzo Therapeutics, Inc.Phase 1/2 Recruiting430 enrolled
NCT04553133 2025-08-28PF-07104091 as a Single Agent and in Combination TherapyPfizerPhase 2 Active not recruiting154 enrolled
NCT05238831 2024-01-23SMMART Adaptive Clinical Treatment (ACT) TrialOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Withdrawn